With advances in technology implants are available today to help treat your retinal and macular disease.
Some options include:
OZURDEX® is a biodegradable implant containing the corticosteroid dexamethasone. Corticosteroids, such as dexamethasone, block chemical pathways that lead to inflammation, leakage from the retinal blood vessels, and edema. OZURDEX® may help reverse some vision loss that may be caused by a retinal vein occlusion or noninfectious uveitis affecting the back segment of the eye.
Retisert is a very small device, about the size of a grain of rice, which contains the corticosteroid fluocinolone acetonide (FA). Retisert is surgically implanted in the eye through a small, 3-4 mm incision and releases precise amounts of medication each day for approximately 2.5 years.
The Vitrasert ganciclovir implant is a sustained-release intravitreal implant that is indicated for the treatment of cytomegalovirus (CMV) retinitis in individuals with acquired immunodeficiency syndrome (AIDS).[1, 2]
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.